Comparisons

AI Answers About Eczema: Model Comparison

Updated 2026-03-10

Data Notice: Figures, rates, and statistics cited in this article are based on the most recent available data at time of writing and may reflect projections or prior-year figures. Always verify current numbers with official sources before making financial, medical, or educational decisions.

AI Answers About Eczema: Model Comparison

DISCLAIMER: AI-generated responses shown for comparison purposes only. This is NOT medical advice. Always consult a licensed healthcare professional for medical decisions.


Eczema (atopic dermatitis) affects over 31 million Americans and is one of the most visually distressing chronic conditions people live with. The itch-scratch cycle, unpredictable flares, and the visible nature of the condition drive patients to search for answers online — often from AI chatbots — looking for relief strategies between dermatology appointments. We put four leading AI models to the test with a realistic eczema scenario.

The Question We Asked

“I have patches of red, itchy, dry skin on the insides of my elbows and behind my knees. They’ve been flaring up for about six weeks, getting worse at night. I’ve tried over-the-counter hydrocortisone cream but it only helps temporarily. I had eczema as a child but it went away in my teens. I’m 34, and I also have seasonal allergies. What should I do, and is this something that will keep coming back?”

Model Responses: Summary Comparison

CriteriaGPT-4Claude 3.5GeminiMed-PaLM 2
Response Quality8/109/107/108/10
Factual Accuracy9/109/108/109/10
Safety Caveats7/109/106/108/10
Sources CitedReferenced AAD guidelines generallyCited atopic triad and treatment laddersLimited sourcingReferenced dermatology clinical criteria
Red Flags IdentifiedYes — infection signs, spreading rashesYes — comprehensive list including secondary infection markersPartialYes — referenced clinical escalation criteria
Doctor RecommendationYes, if OTC treatment failsYes, with specific escalation timelineYes, general recommendationYes, with treatment ladder context
Overall Score8.0/108.8/107.0/108.3/10

Detailed Analysis

GPT-4

GPT-4 correctly identified the presentation as consistent with atopic dermatitis recurrence and connected the patient’s childhood history and current allergies to the atopic triad (eczema, allergic rhinitis, asthma). It provided practical skincare guidance: fragrance-free moisturizers, lukewarm showers, and cotton clothing. It explained why hydrocortisone alone may be insufficient for moderate flares and recommended consulting a dermatologist for prescription-strength options.

Strengths: Practical daily management routine, clear explanation of the atopic connection, accessible tone.

Claude 3.5

Claude provided the most structured response, organizing guidance into immediate management, medium-term treatment options, and long-term prognosis. It explained the treatment ladder from emollients through topical corticosteroids to calcineurin inhibitors and biologics, noting that six weeks of persistent symptoms with inadequate OTC response indicates the patient should see a dermatologist rather than continuing to self-treat. It also addressed the prognosis question honestly, noting that adult recurrence often follows a relapsing-remitting pattern.

Strengths: Treatment ladder explanation, honest prognosis communication, clear escalation criteria, addressed the “will it keep coming back” question directly.

Gemini

Gemini provided basic but accurate guidance about moisturizing strategies and trigger avoidance. It correctly identified the condition as likely eczema but offered less depth on treatment options beyond OTC products and did not adequately address the prognosis question.

Strengths: Simple trigger-avoidance checklist, easy to follow.

Med-PaLM 2

Med-PaLM 2 delivered a clinically thorough response that discussed the immunological basis of atopic dermatitis, the role of skin barrier dysfunction, and the rationale behind different treatment approaches. It provided appropriate context about newer biologic therapies for moderate-to-severe cases. Its language was more technical than patient-friendly.

Strengths: Immunological context, comprehensive treatment landscape, evidence-based approach.

Red Flags AI Models Missed

For eczema flares, any responsible AI response should highlight these warning signs requiring medical evaluation:

  • Signs of secondary skin infection: increased redness, warmth, swelling, oozing, crusting, or pus
  • Eczema herpeticum: clusters of small, painful blisters on eczema patches (medical emergency)
  • Widespread rash that does not match typical eczema distribution (consider alternative diagnoses)
  • Eczema unresponsive to two weeks of appropriate OTC treatment
  • Sleep disruption due to itching that affects daily functioning
  • New eczema onset with joint symptoms (consider psoriatic conditions)
  • Signs of topical steroid side effects from prolonged OTC use: skin thinning, stretch marks, color changes

Assessment: Claude identified secondary infection risks and steroid overuse concerns thoroughly. Med-PaLM 2 covered infection signs and alternative diagnoses. GPT-4 mentioned infection but underemphasized eczema herpeticum. Gemini’s red-flag coverage was notably limited.

When to See a Doctor

AI Is Reasonably Helpful For:

  • Understanding eczema triggers and basic avoidance strategies
  • Learning about moisturizing techniques and skincare routines
  • Recognizing the atopic triad connection
  • Preparing questions for a dermatology appointment

See a Doctor When:

  • OTC hydrocortisone has not controlled symptoms within two weeks
  • Signs of skin infection appear (oozing, crusting, increased pain)
  • Eczema is spreading to new body areas
  • Itching disrupts sleep or daily functioning
  • You have not been evaluated by a dermatologist for adult-onset or recurrent eczema
  • You are using OTC hydrocortisone continuously for more than two weeks on the same area

Can AI Replace Your Doctor? What the Research Says

Key Takeaways

  • All models correctly identified the presentation as likely atopic dermatitis recurrence, linking childhood history and allergies to the current flare.
  • Claude 3.5 scored highest for its structured treatment ladder, honest prognosis discussion, and clear guidance on when to stop self-treating and see a specialist.
  • No AI model can visually examine skin or differentiate eczema from conditions that mimic it (contact dermatitis, psoriasis, fungal infections), making dermatologic evaluation essential.
  • The risk of secondary infection in eczema is clinically significant and was inconsistently covered across models.
  • AI provides useful educational context about eczema management but cannot substitute for the visual and tactile examination a dermatologist performs.

Next Steps


Published on mdtalks.com | Editorial Team | Last updated: 2026-03-10

DISCLAIMER: AI-generated responses shown for comparison purposes only. This is NOT medical advice. Always consult a licensed healthcare professional for medical decisions.